| Literature DB >> 32690569 |
Aditi Sharma1, Krista A Wahby2, Mohammed Inany3, Sarah J Lee3.
Abstract
A 40-year-old woman with a history of chronic graft-versus-host-disease on immunosuppression with tacrolimus presented to the hospital with somnolence, confusion and muscle cramps over a few days. She was found to have hypertension, hyperglycaemia and acute kidney injury with an elevated blood tacrolimus level of greater than 120 ng/mL (reference range 5-15 ng/mL). Discontinuation of tacrolimus with concomitant administration of intravenous phenytoin led to the successful reduction of elevated tacrolimus concentrations and the resolution of her symptoms. Tacrolimus is metabolised by the cytochrome P (CYP) 450 3A enzyme system, and utilisation of CYP 3A inducers to accelerate its clearance may be used as a successful therapy to treat tacrolimus toxicity. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: acute renal failure; adult intensive care; malignant disease and immunosuppression; toxicology
Mesh:
Substances:
Year: 2020 PMID: 32690569 PMCID: PMC7373311 DOI: 10.1136/bcr-2020-234839
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X